Skip to main content


Latest articles

31-03-2019 | Oncology | News | Article

Abiraterone may raise mortality risk in men with prostate cancer, CVD

Among men initiating abiraterone acetate for advanced prostate cancer, the mortality risk may be higher for those with versus without pre-existing cardiovascular disease, suggests a real-world study presented at the AACR Annual Meeting 2019 in Atlanta, Georgia, USA.

27-03-2019 | Cardiovascular | News | Article

Cardiovascular autonomic neuropathy can be reversed in type 2 diabetes

Cardiovascular autonomic neuropathy is reversible in people with type 2 diabetes, report Korean researchers who found that age was the most important predictor of recovery.

22-03-2019 | Cardiovascular | News | Article

HIIT plus resistance training may have cardiovascular benefits in type 2 diabetes

A 1-year exercise intervention combining high-intensity interval training with resistance training may improve measures of cardiovascular risk among people with type 2 diabetes, suggests a secondary analysis of the D2FIT trial.

13-03-2018 | Oncology | News | Article

Data further highlight link between childhood cancer and long-term CVD risk

Young adult survivors of childhood cancer are at increased risk for cardiovascular disease, which develops earlier than in the general population, German study findings confirm.

02-01-2018 | Oncology | News | Article

Cardiovascular toxicity common with carfilzomib for multiple myeloma

Carfilzomib is associated with a high rate of clinically significant cardiovascular adverse events in patients with multiple myeloma, show results of a systematic review and meta-analysis.

11-12-2017 | Rheumatology | News | Article

High coronary plaque burden in PsA patients

Psoriatic arthritis is associated with accelerated coronary plaque formation independently of metabolic disease, according to results from a single-center study.

30-06-2017 | Rheumatology | News | Article

Low disease activity reduces RA-associated CVD risk

Low disease activity could delay the time to first cardiovascular disease event in patients with rheumatoid arthritis.

13-01-2015 | Cardiology | Article

Peripheral muscles weakened in PAH patients

Patients with pulmonary arterial hypertension have peripheral muscle weakness that is independent of impairments in their respiratory muscles, research shows.

13-01-2015 | Cardiology | Article

Concentric remodelling preserves right ventricular function in PAH

Systolic function is better preserved in patients with idiopathic pulmonary arterial hypertension if they have a higher right ventricle mass-to-volume ratio, research shows.

13-01-2015 | Respiratory | Article

CT measures can refine PAH prognosis

Structural features identifiable on computed tomography pulmonary angiography can provide prognostic information for patients with pulmonary arterial hypertension, say UK researchers.

04-12-2014 | Cardiology | Article

PAH markers identified among Chinese systemic sclerosis patients

A study of Chinese patients with systemic sclerosis has identified predictive markers for accompanying pulmonary arterial hypertension similar to those that have been identified in other ethnic groups.

03-12-2014 | Cardiology | Article

Cardiac monitoring foretells clinical deterioration in PAH

Monitoring right ventricular parameters can give advance warning of clinical deterioration in stable patients with idiopathic pulmonary arterial hypertension, research suggests.

02-12-2014 | Cardiology | Article

Noninvasive PAH diagnosis on the horizon

Measuring the duration of vortical blood flow in the main pulmonary artery allows accurate estimation of pulmonary blood pressure and diagnosis of pulmonary arterial hypertension, say researchers.

11-11-2014 | Cardiology | Article

Metabolic syndrome screening in bipolar disorder warranted

The frequency of the metabolic syndrome in patients with bipolar disorder warrants systematic screening, say researchers, particularly among men, older patients and those receiving atypical antipsychotic treatment.

16-10-2014 | Cardiology | Article

Vascular receptor autoantibodies implicated in SSc-PAH

Autoantibodies to endothelin receptor type A and angiotensin receptor type-1 predict the development of, and mortality from, systemic sclerosis-associated pulmonary arterial hypertension, research suggests.

15-10-2014 | Cardiology | Article

HRQoL goals may improve outcome in PAH

Health-related quality of life before and during treatment for pulmonary arterial hypertension is significantly associated with survival, Brazilian researchers report.

14-10-2014 | Cardiology | Article

Noninvasive measure has prognostic value in PAH

Estimated right atrial pressure, measured using echocardiography, may be a useful prognostic indicator in patients with pulmonary arterial hypertension, a study suggests.

28-09-2014 | Cardiology | Article

Targeted treatments may improve idiopathic PAH survival

Patients with idiopathic pulmonary arterial hypertension may live longer if they are given targeted treatments than if they receive conventional management, researchers suggest.

28-09-2014 | Cardiology | Article

Cardiac arrhythmias pose risk in pulmonary hypertension patients

Supraventricular arrhythmias are common and usually cause clinical deterioration in patients with idiopathic pulmonary arterial hypertension, a study shows.

28-09-2014 | Cardiology | Article

Noninvasive diagnosis ‘reliable’ for pulmonary hypertension diagnosis

Doppler echocardiography has good accuracy relative to right heart catheterisation for detecting pulmonary hypertension, shows a large study.